Evaluation of an automated molecular diagnostic instrument for direct detection of Burkholderia pseudomallei from clinical specimens
Journal of Medical Microbiology · 2025
DOI: 10.1099/jmm.0.002074 ↗Kurz gefasst
Evaluationsstudie in der Zeitschrift Journal of Medical Microbiology, 2025. Verfasst von Ian Gassiep und 6 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, UQ Centre for Clinical Research, The University of Queensland, Royal Brisbane & Women's Hospital, Queensland, Brisbane, Australi…. Hauptthemen laut MEDLINE: Burkholderia pseudomallei, Melioidosis, Molecular Diagnostic Techniques, Automation, Laboratory. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Pathology Queensland.
Abstract (Originalsprache)
Background
Melioidosis is a potentially life-threatening infectious disease. The diagnosis of melioidosis is time-critical due to the organism’s intrinsic antimicrobial resistance and requirement for directed therapy.
Aim
To assess the ability of an automated molecular diagnostic instrument to detect Burkholderia pseudomallei directly from clinical samples.
Methods
Urine, sputum, swabs and Ashdown’s (ASH) broth were spiked with known concentrations of B. pseudomallei and analysed using an automated PCR platform (Panther ® Fusion; Hologic) targeting the type III Secretion System (TTS-1) gene. In addition, clinical specimens from patients with confirmed melioidosis were also evaluated.
Results
Urine was the clinical sample that demonstrated the lowest limit of detection (LOD), 1.8×10 2 c.f.u. ml −1 . Compared with dry swabs (LOD: 1.0×10 3 c.f.u. ml −1 ), Amies agar swabs were inferior (LOD: >3.3×10 4 c.f.u. ml −1 ). Inoculation of dry swabs into ASH, with an abbreviated incubation period, did not improve detection. All culture-positive sputum and urine samples from patients with confirmed melioidosis were detected by the PCR method.
Conclusion
This study demonstrates the ability of the Panther ® to directly detect B. pseudomallei across a range of clinical sample types and estimates the minimum bacterial concentration required for diagnostic detection. The described methodology holds promise for expediting diagnosis and, in turn, enhancing patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine, UQ Centre for Clinical Research, The University of Queensland, Royal Brisbane & Women's Hospital, Queensland, Brisbane, Australia.
- Department of Infectious Diseases, Mater Hospital Brisbane, Brisbane, Queensland, Australia.
- Pathology Queensland, Royal Brisbane & Women's Hospital, Queensland, Brisbane, Australia.
- Pathology Queensland, Townsville University Hospital, Townsville, Queensland, Australia.
- Pathology Queensland, Cairns Hospital, Cairns, Queensland, Australia.
- Department of Infectious Diseases, Cairns Hospital, Cairns, Queensland, Australia.
Förderung
- Pathology Queensland
Zitieren
APA
Gassiep, I., Glover, M., Beecham, M., Gorman, B., Page, M., Stewart, J., & Harris, P. N. A. (2025). Evaluation of an automated molecular diagnostic instrument for direct detection of Burkholderia pseudomallei from clinical specimens. Journal of Medical Microbiology. https://doi.org/10.1099/jmm.0.002074
Vancouver
Gassiep I, Glover M, Beecham M, Gorman B, Page M, Stewart J, et al. Evaluation of an automated molecular diagnostic instrument for direct detection of Burkholderia pseudomallei from clinical specimens. Journal of Medical Microbiology. 2025. doi:10.1099/jmm.0.002074
BibTeX
@article{Gassiep2025,
author = {Gassiep, Ian and Glover, Matthew and Beecham, Mark and Gorman, Brian and Page, Melissa and Stewart, James and Harris, Patrick N A},
title = {Evaluation of an automated molecular diagnostic instrument for direct detection of Burkholderia pseudomallei from clinical specimens},
journal = {Journal of Medical Microbiology},
year = {2025},
doi = {10.1099/jmm.0.002074}
}
EUVIMED